Yihong Yao

5.7k total citations · 1 hit paper
61 papers, 4.0k citations indexed

About

Yihong Yao is a scholar working on Immunology, Oncology and Rheumatology. According to data from OpenAlex, Yihong Yao has authored 61 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Immunology, 19 papers in Oncology and 17 papers in Rheumatology. Recurrent topics in Yihong Yao's work include Systemic Lupus Erythematosus Research (11 papers), T-cell and B-cell Immunology (11 papers) and Inflammatory Myopathies and Dermatomyositis (10 papers). Yihong Yao is often cited by papers focused on Systemic Lupus Erythematosus Research (11 papers), T-cell and B-cell Immunology (11 papers) and Inflammatory Myopathies and Dermatomyositis (10 papers). Yihong Yao collaborates with scholars based in United States, China and France. Yihong Yao's co-authors include Bahija Jallal, Brandon W. Higgs, Nan Shen, Laura K. Richman, Chris Morehouse, Jiaqi Huang, Haihong Zhong, Peter A. Kiener, Michael Fung and Xin Yao and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.

In The Last Decade

Yihong Yao

60 papers receiving 3.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Targeting interleukin-6 in inflammatory autoimmune diseases and cancers

2013 529 citations Xin Yao, Jiaqi Huang et al. Pharmacology & Therapeutics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yihong Yao United States	33	1.8k	1.3k	1.3k	872	855	61	4.0k
Hiroaki Niiro Japan	43	2.8k 1.6×	878 0.7×	1.3k 1.0×	576 0.7×	843 1.0×	145	5.4k
Fabia Brentano Switzerland	21	1.2k 0.7×	924 0.7×	1.1k 0.8×	370 0.4×	530 0.6×	23	2.9k
Ping Zhu China	34	1.8k 1.0×	1.2k 0.9×	1.4k 1.1×	205 0.2×	532 0.6×	142	3.7k
Vasileios C. Kyttaris United States	42	3.8k 2.1×	2.7k 2.0×	918 0.7×	219 0.3×	885 1.0×	116	5.2k
Annegret Kuhn Germany	41	2.8k 1.5×	2.8k 2.1×	918 0.7×	462 0.5×	485 0.6×	136	5.3k
Carmelo Carmona‐Rivera United States	31	4.3k 2.4×	1.2k 0.9×	2.2k 1.7×	424 0.5×	367 0.4×	52	5.9k
Ayumi Yoshizaki Japan	34	2.2k 1.2×	481 0.4×	962 0.7×	722 0.8×	919 1.1×	192	4.8k
Maarten C. Kraan Netherlands	33	1.2k 0.7×	2.5k 1.8×	937 0.7×	173 0.2×	782 0.9×	53	4.1k
Junya Kuroda Japan	34	950 0.5×	392 0.3×	2.0k 1.6×	289 0.3×	1.5k 1.8×	217	4.7k
Kunihiro Ichinose Japan	31	1.2k 0.7×	1.3k 1.0×	773 0.6×	281 0.3×	316 0.4×	188	3.1k

Countries citing papers authored by Yihong Yao

Since Specialization

Citations

This map shows the geographic impact of Yihong Yao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yihong Yao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yihong Yao more than expected).

Fields of papers citing papers by Yihong Yao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yihong Yao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yihong Yao. The network helps show where Yihong Yao may publish in the future.

Co-authorship network of co-authors of Yihong Yao

This figure shows the co-authorship network connecting the top 25 collaborators of Yihong Yao. A scholar is included among the top collaborators of Yihong Yao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yihong Yao. Yihong Yao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Ning, Liyu Huang, Mengnan Zhao, et al.. (2025). Trends in diet structural composition and quality among adults in Beijing, China (2010–2022). Frontiers in Nutrition. 12. 1610823–1610823.

Cai, Lun, Leidy D. Caraballo Galva, Yibing Peng, et al.. (2020). Preclinical Studies of the Off-Target Reactivity of AFP158-Specific TCR Engineered T Cells. Frontiers in Immunology. 11. 607–607. 20 indexed citations

Luo, Xiaobing, Huijuan Cui, Lun Cai, et al.. (2020). Selection of a Clinical Lead TCR Targeting Alpha-Fetoprotein-Positive Liver Cancer Based on a Balance of Risk and Benefit. Frontiers in Immunology. 11. 623–623. 27 indexed citations

Yao, Yihong, Da Huo, & Lei Jia. (2018). Early warning models for hand, foot, and mouth disease and their applications. 25(2). 136–139. 1 indexed citations

Cui, Shaohua, Xinying Su, Lili Dong, et al.. (2017). Programmed cell death ligand 1 protein levels predicted survival of non-small cell lung cancer. Journal of Cancer. 8(19). 4075–4082. 7 indexed citations

Zhong, Haihong, April Davis, Maria Ouzounova, et al.. (2016). A Novel IL6 Antibody Sensitizes Multiple Tumor Types to Chemotherapy Including Trastuzumab-Resistant Tumors. Cancer Research. 76(2). 480–490. 40 indexed citations

Delaney, Tracy, Chris Morehouse, Philip Z. Brohawn, et al.. (2016). Type I IFNs Regulate Inflammation, Vasculopathy, and Fibrosis in Chronic Cutaneous Graft-versus-Host Disease. The Journal of Immunology. 197(1). 42–50. 27 indexed citations

Xue, Feng, Brandon W. Higgs, Jiaqi Huang, et al.. (2015). HERC5 is a prognostic biomarker for post-liver transplant recurrent human hepatocellular carcinoma. Journal of Translational Medicine. 13(1). 379–379. 27 indexed citations

Zhong, Haihong, Christine Fazenbaker, Shannon Breen, et al.. (2014). MEDI-573, Alone or in Combination with Mammalian Target of Rapamycin Inhibitors, Targets the Insulin-like Growth Factor Pathway in Sarcomas. Molecular Cancer Therapeutics. 13(11). 2662–2673. 20 indexed citations

10.

Jiang, Liyan, Wei Zhu, Katie Streicher, et al.. (2014). Increased IR-A/IR-B ratio in non-small cell lung cancers associates with lower epithelial-mesenchymal transition signature and longer survival in squamous cell lung carcinoma. BMC Cancer. 14(1). 131–131. 27 indexed citations

11.

Petri, Michelle, Daniel J. Wallace, Alberto Spindler, et al.. (2013). Sifalimumab, a Human Anti–Interferon‐α Monoclonal Antibody, in Systemic Lupus Erythematosus: A Phase I Randomized, Controlled, Dose‐Escalation Study. Arthritis & Rheumatism. 65(4). 1011–1021. 200 indexed citations

12.

Jiang, Liyan, Jiaqi Huang, Chris Morehouse, et al.. (2013). Low frequency KRAS mutations in colorectal cancer patients and the presence of multiple mutations in oncogenic drivers in non-small cell lung cancer patients. Cancer Genetics. 206(9-10). 330–339. 14 indexed citations

13.

Bao, Haifeng, Peter Burke, Jiaqi Huang, et al.. (2013). Circulating Tumor Cells: Application as a Biomarker for Molecular Characterization and Predictor of Survival in an All-Comer Solid Tumor Phase I Clinical Study. PLoS ONE. 8(8). e58557–e58557. 14 indexed citations

14.

Yao, Xin, Jiaqi Huang, Haihong Zhong, et al.. (2013). Targeting interleukin-6 in inflammatory autoimmune diseases and cancers. Pharmacology & Therapeutics. 141(2). 125–139. 529 indexed citations breakdown →

15.

Yao, Yihong, Zheng Liu, Bahija Jallal, Nan Shen, & Lars Rönnblom. (2012). Type I interferons in Sjögren's syndrome. Autoimmunity Reviews. 12(5). 558–566. 104 indexed citations

16.

Higgs, Brandon W., Wei Zhu, Laura K. Richman, et al.. (2011). Identification of activated cytokine pathways in the blood of systemic lupus erythematosus, myositis, rheumatoid arthritis, and scleroderma patients. International Journal of Rheumatic Diseases. 15(1). 25–35. 50 indexed citations

17.

Salajegheh, Mohammad, Jack L. Pinkus, Anthony A. Amato, et al.. (2010). Permissive environment for B‐cell maturation in myositis muscle in the absence of B‐cell follicles. Muscle & Nerve. 42(4). 576–583. 54 indexed citations

18.

Yao, Yihong, Brandon W. Higgs, Chris Morehouse, et al.. (2008). Development of Potential Pharmacodynamic and Diagnostic Markers for Anti-IFN-α Monoclonal Antibody Trials in Systemic Lupus Erythematosus. PubMed. 1(1). 100 indexed citations

19.

Yao, Yihong, Laura K. Richman, Chris Morehouse, et al.. (2008). Type I Interferon: Potential Therapeutic Target for Psoriasis?. PLoS ONE. 3(7). e2737–e2737. 257 indexed citations

20.

Walsh, Ronan J., Sek Won Kong, Yihong Yao, et al.. (2007). Type I interferon–inducible gene expression in blood is present and reflects disease activity in dermatomyositis and polymyositis. Arthritis & Rheumatism. 56(11). 3784–3792. 236 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact